Could NICE guidance on the choice of blood pressure lowering drugs be simplified? - sprookjes - yvandenbroek - TriplyDB

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

http://www.wikidata.org/entity/Q37642778

about

Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension

P2860

Q24632816-0020BD21-4B1A-4BEC-AFCE-EF45E91C0850

P2860

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

http://www.wikidata.org/entity/Q37642778

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 January 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@en

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@nl

type

label

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@en

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@nl

prefLabel

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@en

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@nl

P1433

Q37642778-4CFE8176-B8BC-4FE4-855F-B2FCC3564575

P1476

Q37642778-A7295998-369B-43ED-8694-D6689531EDF2

P2093

Q37642778-43C9BA73-1CB7-4E58-ADC6-CD7AA9FAC5B8

Q37642778-4B5DE4CD-24CE-42BD-886A-8F5F420477C1

Q37642778-713BE98F-5D9D-48AF-9183-ABCA2CE338E6

Q37642778-E3980638-87FD-4BA5-8DBE-3DC5369B0BEB

Q37642778-F2DD295D-A879-493D-B47F-5C5C25E13FC6

P2860

Q37642778-015A51B4-F15A-4F97-A45F-B9017DE912AC

Q37642778-0912DA9B-40F1-4174-A60A-212798239CEF

Q37642778-0E5F1742-F9F8-4FA4-A5CD-99A9C2302B05

Q37642778-137F3DEF-95C9-482D-A7B5-DC15BF961939

Q37642778-2013F45A-9ED8-4D17-B6D5-E231F393578C

Q37642778-32514D14-1F5A-4372-8D32-C95C97F757A5

Q37642778-3B85587F-56B0-4A26-8CAA-859038CC4883

Q37642778-427F2223-8859-4C2F-958F-7EAC68CA173B

Q37642778-44E4E3F1-215F-4630-A9B4-B337F5767C2E

Q37642778-5FA97F88-B319-4AC6-A4B6-6316AB742714

P304

Q37642778-6E7F6AC5-F9DF-431C-95A4-241929ED666B

P31

Q37642778-D0468EE1-01AC-4547-A0B9-40AAF717A9AB

P356

Q37642778-5047AFD8-FDDE-421C-8FDD-3674CB95D0C0

P407

Q37642778-B741F302-275E-402E-B1F0-81DC4671562B

P478

Q37642778-E0B1E995-227E-497C-92D4-6D349051264C

P50

Q37642778-ABF1F716-FEF5-4218-B25F-06E3B8EFC48D

Q37642778-CF4A41BA-748E-4274-8C90-3FEBFECE8A78

P577

Q37642778-5569F873-8ABA-466A-AF65-052B2A17CC82

P5875

Q37642778-035A74E1-00C2-4AAD-8D83-1600FB1C941B

P698

Q37642778-BE5225A3-0440-4673-8010-1C1CB9468E86

P932

Q37642778-CAE8F76B-BD0E-495C-AC6D-3A6EBF0227A3

P356

P1433

P1476

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

@en

P2093

Anthony M Grosso

http://www.w3.org/2001/XMLSchema#string

Brian N C Prichard

http://www.w3.org/2001/XMLSchema#string

Juan P Casas

http://www.w3.org/2001/XMLSchema#string

Raymond MacAllister

http://www.w3.org/2001/XMLSchema#string

Reecha Sofat

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

P304

d8078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.D8078

http://www.w3.org/2001/XMLSchema#string

P407

P478

344

http://www.w3.org/2001/XMLSchema#string

P50

Aroon Hingorani

P577

2012-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221748563

http://www.w3.org/2001/XMLSchema#string

P698

22246267

http://www.w3.org/2001/XMLSchema#string

P932

3957318

http://www.w3.org/2001/XMLSchema#string